Top Menu

News Update

FDA initiated to ban menthol cigarettes in the US
Flavored tobacco products, particularly menthol cigarettes, attract the young generation in the US to use, therefore the Food and Drug Administration (FDA) proposed to ban the sales of menthol-flavored cigarettes to protect health of youngsters.

Menthol-flavored tobacco product is the most accessible way for the youth in the US to get exposure to combustible cigarettes for the first time. The menthol flavor could cover up the unpleasant features, such as the harshness, bitterness and astringency of tobacco products, and the irritation during use.

Studies showed that people who have ever tried flavored tobacco products in their young age were found to have higher prevalence of current tobacco use. Specifically, youth who first used menthol cigarettes were more likely to establish smoking and nicotine dependence than those who started with non-menthol cigarettes. The prohibition of sales of menthol-flavored cigarettes is reckoned to be the effective method to reduce the attractiveness and addictiveness to tobacco products in youth and children.

On the other hand, over 2 million US secondary school students have used e-cigarettes in 2017, which was described as an epidemic by the FDA Commissioner. To prevent the young generation from addiction to nicotine products, FDA also planned to ban the online sale of flavored e-cigarettes and impose a variety of strict regulations on the sale and promotion of e-cigarettes.

In Hong Kong, the Chief Executive announced in the 2018 Policy Address to legislate for the total ban of e-cigarettes and other new smoking products, including heat-not-burn tobacco products. In order to protect the youngsters from harms of tobacco and safeguard public health, COSH urges the Government and Legislative Council to enact the legislation as soon as possible and formulate a timeline to ban smoking.

Please sign to support COSH’s “Support to enact a total ban on e-cigarettes and other new tobacco products” Signatory Campaign.

Source: Food and Drug Administration
Back to Top